Exact Sciences
EXAS
#1715
Rank
A$15.22 B
Marketcap
$82.28
Share price
0.74%
Change (1 day)
-17.15%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.36

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.44. In 2022 the company made an earnings per share (EPS) of -$5.45 a decrease over its 2021 EPS that were of -$5.32.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.36-56.75%
2022-$5.452.31%
2021-$5.32-37.09%
2020-$8.46674.65%
2019-$1.09-50.69%
2018-$2.2244%
2017-$1.54-39.39%
2016-$2.54-2.94%
2015-$2.6237.1%
2014-$1.9179.71%
2013-$1.06-21.59%
2012-$1.3562.96%
2011-$0.8392.86%
2010-$0.43-3.45%
2009-$0.45-19.44%
2008-$0.55-18.18%
2007-$0.68-10.2%
2006-$0.75-10.91%
2005-$0.85-24.66%
2004-$1.12-51.33%
2003-$2.31-7.41%
2002-$2.4911.72%
2001-$2.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$4.68 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.52-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.62-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$78.33 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.89-300.57%๐Ÿ‡ซ๐Ÿ‡ท France